{"nctId":"NCT01406938","briefTitle":"Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens","startDateStruct":{"date":"2011-08"},"conditions":["Moderate to Severe Plaque-type Psoriasis"],"count":967,"armGroups":[{"label":"AIN457150 mg- Induction period Only(IPO)","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 150mg"]},{"label":"AIN457 300 mg - IPO","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 300mg"]},{"label":"AIN457 150 mg - Fixed Interval (FI)","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 150mg"]},{"label":"AIN457 300 mg FI","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 300mg"]},{"label":"AIN457 150 mg- Start of relapse (SoR)","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 150mg"]},{"label":"AIN457 300 mg- SoR","type":"EXPERIMENTAL","interventionNames":["Drug: AIN457 300mg"]}],"interventions":[{"name":"AIN457 150mg","otherNames":["secukinumab 150 mg"]},{"name":"AIN457 300mg","otherNames":["secukinumab"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n* Moderate and severe plaque-type psoriasis diagnosed for at least 6 months.\n\nSeverity of disease meeting all of the following three criteria:\n\n* PASI score of 12 or greater,\n* Investigator's Global Assessment (IGA) score of 3 or greater\n* Total body surface area (BSA) affected of 10% or greater.\n* Inadequate control by prior use of topical treatment, phototherapy and/or systemic therapy.\n\nExclusion criteria:\n\n* Current forms of psoriasis other than chronic plaque-type psoriasis (for example, pustular, erythrodermic, guttate).\n* Current drug-induced psoriasis.\n* Previous use of secukinumab or any drug that targets IL-17 or IL-17 receptor.\n* Significant medical problems such as uncontrolled hypertension, congestive heart failure or a condition that significantly immunocompromises the subject.\n* Hematological abnormalities.\n* History of an ongoing, chronic or recurrent infectious disease, or evidence of untreated tuberculosis.\n* History of lymphoproliferative disease or history of malignancy of any organ system within the past 5 years.\n* Pregnant or nursing (lactating) women.\n* Other protocol-defined inclusion/exclusion criteria may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"For the Fixed Interval Group and the Start of Relapse (SoR) Group, the Percentage of Participants (Who Responded to Treatment at Week 12) Maintaining a 75% Improvement From Baseline in Psoriasis Area and Severity Index (PASI) Score at Week 52","description":"PASI: Combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72(maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section(head: 0.1, arms: 0.2 body: 0.3 legs: 0.4)","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"62.1","spread":null},{"groupId":"OG003","value":"78.2","spread":null},{"groupId":"OG004","value":"52.4","spread":null},{"groupId":"OG005","value":"67.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline for PASI 50 / 75 / 90 / 100 and IGA 2011 Score of 0 or 1 at Week 2, 4, 6, 8, 12","description":"PASI: Combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72(maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section(head:01, arms:0.2 body:0.3 legs:0.4)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.46","spread":"6.338"},{"groupId":"OG001","value":"-9.28","spread":"6.752"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.13","spread":"7.826"},{"groupId":"OG001","value":"-12.97","spread":"7.826"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.18","spread":"8.956"},{"groupId":"OG001","value":"-15.90","spread":"8.838"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.69","spread":"10.147"},{"groupId":"OG001","value":"-19.56","spread":"9.356"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.71","spread":"10.804"},{"groupId":"OG001","value":"-20.89","spread":"9.584"}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline for PASI 50 / 75 / 90 / 100 and IGA 2011 Score of 0 or 1 at Week at Week 16, 20, 24,28,32,36,40,44,48,and Week 52","description":"PASI: Combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72(maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section(head:01, arms:0.2 body:0.3 legs:0.4)","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"-21.52","spread":"9.553"},{"groupId":"OG003","value":"-22.32","spread":"8.943"},{"groupId":"OG004","value":"-23.19","spread":"11.063"},{"groupId":"OG005","value":"-21.58","spread":"9.448"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-21.23","spread":"9.676"},{"groupId":"OG003","value":"-22.61","spread":"9.310"},{"groupId":"OG004","value":"-23.26","spread":"11.158"},{"groupId":"OG005","value":"-21.58","spread":"9.626"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-20.79","spread":"9.739"},{"groupId":"OG003","value":"-22.47","spread":"9.237"},{"groupId":"OG004","value":"-22.28","spread":"11.548"},{"groupId":"OG005","value":"-20.97","spread":"9.787"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-20.61","spread":"9.745"},{"groupId":"OG003","value":"-22.30","spread":"9.262"},{"groupId":"OG004","value":"-21.36","spread":"11.938"},{"groupId":"OG005","value":"-20.09","spread":"9.904"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-20.29","spread":"9.730"},{"groupId":"OG003","value":"-22.13","spread":"9.244"},{"groupId":"OG004","value":"-20.53","spread":"11.754"},{"groupId":"OG005","value":"-19.27","spread":"9.844"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-20.11","spread":"9.847"},{"groupId":"OG003","value":"-21.98","spread":"9.195"},{"groupId":"OG004","value":"-19.41","spread":"10.962"},{"groupId":"OG005","value":"-18.68","spread":"9.983"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-19.82","spread":"9.908"},{"groupId":"OG003","value":"-21.79","spread":"9.324"},{"groupId":"OG004","value":"-18.86","spread":"10.625"},{"groupId":"OG005","value":"-18.14","spread":"9.352"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-19.51","spread":"9.821"},{"groupId":"OG003","value":"-21.71","spread":"9.369"},{"groupId":"OG004","value":"-18.30","spread":"10.660"},{"groupId":"OG005","value":"-17.89","spread":"9.837"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-19.40","spread":"9.691"},{"groupId":"OG003","value":"-21.58","spread":"9.398"},{"groupId":"OG004","value":"-17.73","spread":"11.041"},{"groupId":"OG005","value":"-17.03","spread":"9.876"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-19.04","spread":"10.093"},{"groupId":"OG003","value":"-21.34","spread":"9.681"},{"groupId":"OG004","value":"-17.48","spread":"10.638"},{"groupId":"OG005","value":"-16.58","spread":"9.040"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-18.79","spread":"9.904"},{"groupId":"OG003","value":"21.47","spread":"9.402"},{"groupId":"OG004","value":"-17.40","spread":"10.719"},{"groupId":"OG005","value":"-16.33","spread":"8.322"}]}]}]},{"type":"SECONDARY","title":"Percent of Participants Achieving Psoriasis Area & Severity Index (PASI) Score and IGA Mod 2011 0 or 1 Score Over Time at Week 12 and 52 (Induction)","description":"PASI is a combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72 (maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section (head: 0.1, arms: 0.2 body: 0.3 legs: 0.4). PASI 50, 75, 90 and 100 were defined as participants achieving ≥ 50%, 75%, 90% or 100% improvement from baseline. The IGA mod 2011 scale is static, i.e. it referred exclusively to the participant's disease at the time of the assessment, and did not compare with any of the participant's previous disease states at previous visits. The scores are: 0 = clear, 1 = almost clear, 2 = mild, 3 = moderate and 4 = severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":null},{"groupId":"OG001","value":"3.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":null},{"groupId":"OG001","value":"5.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.2","spread":null},{"groupId":"OG001","value":"32.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","spread":null},{"groupId":"OG001","value":"9.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"19.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"63.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":null},{"groupId":"OG001","value":"3.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.6","spread":null},{"groupId":"OG001","value":"25.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27.9","spread":null},{"groupId":"OG001","value":"42.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.3","spread":null},{"groupId":"OG001","value":"81.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"13.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.8","spread":null},{"groupId":"OG001","value":"59.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63.8","spread":null},{"groupId":"OG001","value":"76.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.4","spread":null},{"groupId":"OG001","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.4","spread":null},{"groupId":"OG001","value":"45.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.3","spread":null},{"groupId":"OG001","value":"13.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.8","spread":null},{"groupId":"OG001","value":"76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"84.4","spread":null},{"groupId":"OG001","value":"90.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93.1","spread":null},{"groupId":"OG001","value":"96.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.3","spread":null},{"groupId":"OG001","value":"64.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.2","spread":null},{"groupId":"OG001","value":"25.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent of Participants Achieving Psoriasis Area & Severity Index (PASI) Score and IGA Mod 2011 0 or 1 Score Over Time at Week 12 and 52 (Maintenance Period))","description":"The IGA mod 2011 is a static scale, i.e., it refers exclusively to the participant's disease state at the time of the assessments and does not attempt a comparison to any of the participant's previous disease states at prior visits. The score ranges from 0 (clear) to 4 (severe. The score 0 is clear, 1 is almost clear, 2 is mild, 3 is moderate, and 4 is severe","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"70.9","spread":null},{"groupId":"OG003","value":"82.4","spread":null},{"groupId":"OG004","value":"74.8","spread":null},{"groupId":"OG005","value":"83.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"90.1","spread":null},{"groupId":"OG003","value":"92.1","spread":null},{"groupId":"OG004","value":"92.7","spread":null},{"groupId":"OG005","value":"94.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"96.1","spread":null},{"groupId":"OG003","value":"97.7","spread":null},{"groupId":"OG004","value":"98.1","spread":null},{"groupId":"OG005","value":"98.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"59.1","spread":null},{"groupId":"OG003","value":"75.5","spread":null},{"groupId":"OG004","value":"68.4","spread":null},{"groupId":"OG005","value":"76.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"27.6","spread":null},{"groupId":"OG003","value":"31.5","spread":null},{"groupId":"OG004","value":"22.3","spread":null},{"groupId":"OG005","value":"38.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"69","spread":null},{"groupId":"OG003","value":"75.5","spread":null},{"groupId":"OG004","value":"64.6","spread":null},{"groupId":"OG005","value":"77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"85.7","spread":null},{"groupId":"OG003","value":"90.3","spread":null},{"groupId":"OG004","value":"81.6","spread":null},{"groupId":"OG005","value":"87.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"94.6","spread":null},{"groupId":"OG003","value":"97.7","spread":null},{"groupId":"OG004","value":"92.2","spread":null},{"groupId":"OG005","value":"97.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"62.6","spread":null},{"groupId":"OG003","value":"74.5","spread":null},{"groupId":"OG004","value":"55.8","spread":null},{"groupId":"OG005","value":"72.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"29.1","spread":null},{"groupId":"OG003","value":"35.6","spread":null},{"groupId":"OG004","value":"24.8","spread":null},{"groupId":"OG005","value":"35.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"67.5","spread":null},{"groupId":"OG003","value":"76.9","spread":null},{"groupId":"OG004","value":"56.3","spread":null},{"groupId":"OG005","value":"65.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"80.3","spread":null},{"groupId":"OG003","value":"88","spread":null},{"groupId":"OG004","value":"72.3","spread":null},{"groupId":"OG005","value":"77.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"93.1","spread":null},{"groupId":"OG003","value":"94.9","spread":null},{"groupId":"OG004","value":"89.3","spread":null},{"groupId":"OG005","value":"94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"66.5","spread":null},{"groupId":"OG003","value":"74.1","spread":null},{"groupId":"OG004","value":"51.5","spread":null},{"groupId":"OG005","value":"59.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"29.1","spread":null},{"groupId":"OG003","value":"36.1","spread":null},{"groupId":"OG004","value":"19.9","spread":null},{"groupId":"OG005","value":"26.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"65.5","spread":null},{"groupId":"OG003","value":"72.7","spread":null},{"groupId":"OG004","value":"44.7","spread":null},{"groupId":"OG005","value":"52.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"77.3","spread":null},{"groupId":"OG003","value":"85.6","spread":null},{"groupId":"OG004","value":"65","spread":null},{"groupId":"OG005","value":"71.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"92.6","spread":null},{"groupId":"OG003","value":"93.5","spread":null},{"groupId":"OG004","value":"87.4","spread":null},{"groupId":"OG005","value":"94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"60.6","spread":null},{"groupId":"OG003","value":"70.4","spread":null},{"groupId":"OG004","value":"40.8","spread":null},{"groupId":"OG005","value":"50.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"29.6","spread":null},{"groupId":"OG003","value":"38","spread":null},{"groupId":"OG004","value":"15.5","spread":null},{"groupId":"OG005","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"64","spread":null},{"groupId":"OG003","value":"74.1","spread":null},{"groupId":"OG004","value":"33.5","spread":null},{"groupId":"OG005","value":"46.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"74.9","spread":null},{"groupId":"OG003","value":"84.3","spread":null},{"groupId":"OG004","value":"50.5","spread":null},{"groupId":"OG005","value":"63.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"91.1","spread":null},{"groupId":"OG003","value":"92.6","spread":null},{"groupId":"OG004","value":"82","spread":null},{"groupId":"OG005","value":"90.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"58.6","spread":null},{"groupId":"OG003","value":"74.1","spread":null},{"groupId":"OG004","value":"32.5","spread":null},{"groupId":"OG005","value":"41.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"30.5","spread":null},{"groupId":"OG003","value":"38.9","spread":null},{"groupId":"OG004","value":"10.7","spread":null},{"groupId":"OG005","value":"15.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"59.6","spread":null},{"groupId":"OG003","value":"70.4","spread":null},{"groupId":"OG004","value":"27.2","spread":null},{"groupId":"OG005","value":"33.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"71.4","spread":null},{"groupId":"OG003","value":"82.9","spread":null},{"groupId":"OG004","value":"45.1","spread":null},{"groupId":"OG005","value":"58.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"87.7","spread":null},{"groupId":"OG003","value":"91.2","spread":null},{"groupId":"OG004","value":"78.6","spread":null},{"groupId":"OG005","value":"94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"54.7","spread":null},{"groupId":"OG003","value":"68.1","spread":null},{"groupId":"OG004","value":"24.8","spread":null},{"groupId":"OG005","value":"35.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"28.6","spread":null},{"groupId":"OG003","value":"38.9","spread":null},{"groupId":"OG004","value":"2.9","spread":null},{"groupId":"OG005","value":"7.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"53.2","spread":null},{"groupId":"OG003","value":"68.5","spread":null},{"groupId":"OG004","value":"26.2","spread":null},{"groupId":"OG005","value":"35.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"68","spread":null},{"groupId":"OG003","value":"81.5","spread":null},{"groupId":"OG004","value":"42.2","spread":null},{"groupId":"OG005","value":"58.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"87.7","spread":null},{"groupId":"OG003","value":"90.7","spread":null},{"groupId":"OG004","value":"74.8","spread":null},{"groupId":"OG005","value":"88.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"52.2","spread":null},{"groupId":"OG003","value":"68.5","spread":null},{"groupId":"OG004","value":"18.9","spread":null},{"groupId":"OG005","value":"26.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"26.1","spread":null},{"groupId":"OG003","value":"38","spread":null},{"groupId":"OG004","value":"1.9","spread":null},{"groupId":"OG005","value":"7.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"52.7","spread":null},{"groupId":"OG003","value":"64.8","spread":null},{"groupId":"OG004","value":"20.4","spread":null},{"groupId":"OG005","value":"27.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"66","spread":null},{"groupId":"OG003","value":"80.1","spread":null},{"groupId":"OG004","value":"37.4","spread":null},{"groupId":"OG005","value":"51.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"84.2","spread":null},{"groupId":"OG003","value":"92.1","spread":null},{"groupId":"OG004","value":"72.8","spread":null},{"groupId":"OG005","value":"82.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"49.8","spread":null},{"groupId":"OG003","value":"66.2","spread":null},{"groupId":"OG004","value":"16.5","spread":null},{"groupId":"OG005","value":"22.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"22.7","spread":null},{"groupId":"OG003","value":"39.8","spread":null},{"groupId":"OG004","value":"1.5","spread":null},{"groupId":"OG005","value":"4.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"51.7","spread":null},{"groupId":"OG003","value":"64.8","spread":null},{"groupId":"OG004","value":"20.4","spread":null},{"groupId":"OG005","value":"21.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"65.5","spread":null},{"groupId":"OG003","value":"78.7","spread":null},{"groupId":"OG004","value":"33","spread":null},{"groupId":"OG005","value":"45.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"83.3","spread":null},{"groupId":"OG003","value":"89.8","spread":null},{"groupId":"OG004","value":"74.8","spread":null},{"groupId":"OG005","value":"82","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"49.8","spread":null},{"groupId":"OG003","value":"62.5","spread":null},{"groupId":"OG004","value":"12.6","spread":null},{"groupId":"OG005","value":"14.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"21.2","spread":null},{"groupId":"OG003","value":"38.4","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"3.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"47.3","spread":null},{"groupId":"OG003","value":"59.3","spread":null},{"groupId":"OG004","value":"18","spread":null},{"groupId":"OG005","value":"20.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"62.1","spread":null},{"groupId":"OG003","value":"78.2","spread":null},{"groupId":"OG004","value":"35","spread":null},{"groupId":"OG005","value":"41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"83.7","spread":null},{"groupId":"OG003","value":"87.5","spread":null},{"groupId":"OG004","value":"73.8","spread":null},{"groupId":"OG005","value":"81.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"45.8","spread":null},{"groupId":"OG003","value":"59.7","spread":null},{"groupId":"OG004","value":"11.2","spread":null},{"groupId":"OG005","value":"13.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"21.2","spread":null},{"groupId":"OG003","value":"36.6","spread":null},{"groupId":"OG004","value":"2.4","spread":null},{"groupId":"OG005","value":"5.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in EQ-5D at Each Visit, up to Week 52, (Induction)","description":"ED-5Q: Participant rated questionnaire to assess health related quality of life in terms of a single utility score. Five domains are assessed mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) each with three possible score: 1 indicates no problems, better state of health; 3 indicates worst state of health (example \"confined to bed\") A visual analog scale (VAS) assesses the health status from 0 (worst possible health state) to 100 (best possible health state)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"14.64"},{"groupId":"OG001","value":"7.6","spread":"12.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.8","spread":"17.79"},{"groupId":"OG001","value":"13.6","spread":"18.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.5","spread":"20.79"},{"groupId":"OG001","value":"18.3","spread":"21.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.2","spread":"23.47"},{"groupId":"OG001","value":"21.2","spread":"24.08"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in EQ-5D at Each Visit, up to Week 52, (Maintenance)","description":"ED-5Q: Participant rated questionnaire to assess health related quality of life in terms of a single utility score. Five domains are assessed mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) each with three possible score: 1 indicates no problems, better state of health; 3 indicates worst state of health (example \"confined to bed\") A visual analog scale (VAS) assesses the health status from 0 (worst possible health state) to 100 (best possible health state)","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"21.4","spread":"25.11"},{"groupId":"OG003","value":"23","spread":"22.44"},{"groupId":"OG004","value":"23.4","spread":"25.31"},{"groupId":"OG005","value":"23.9","spread":"26.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"20.6","spread":"25.07"},{"groupId":"OG003","value":"23","spread":"23.27"},{"groupId":"OG004","value":"22.1","spread":"26.04"},{"groupId":"OG005","value":"22.4","spread":"27.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"20.6","spread":"25.05"},{"groupId":"OG003","value":"22.9","spread":"23.32"},{"groupId":"OG004","value":"20","spread":"26.66"},{"groupId":"OG005","value":"22.3","spread":"26.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.4","spread":"26.46"},{"groupId":"OG003","value":"23","spread":"22.71"},{"groupId":"OG004","value":"19.3","spread":"25.07"},{"groupId":"OG005","value":"20.4","spread":"26.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"20.4","spread":"24.95"},{"groupId":"OG003","value":"22.8","spread":"23.22"},{"groupId":"OG004","value":"17.9","spread":"24.97"},{"groupId":"OG005","value":"18.8","spread":"25.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.6","spread":"25.79"},{"groupId":"OG003","value":"23","spread":"22.67"},{"groupId":"OG004","value":"17.4","spread":"24.30"},{"groupId":"OG005","value":"17.7","spread":"26.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.8","spread":"25.39"},{"groupId":"OG003","value":"22.8","spread":"22.69"},{"groupId":"OG004","value":"16.3","spread":"23.53"},{"groupId":"OG005","value":"16.4","spread":"26.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.8","spread":"25.53"},{"groupId":"OG003","value":"22.3","spread":"23.10"},{"groupId":"OG004","value":"15.4","spread":"23.70"},{"groupId":"OG005","value":"14.9","spread":"26.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.7","spread":"25.33"},{"groupId":"OG003","value":"22.7","spread":"22.85"},{"groupId":"OG004","value":"16.2","spread":"23.17"},{"groupId":"OG005","value":"13.4","spread":"26.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"18.3","spread":"25.63"},{"groupId":"OG003","value":"23","spread":"22.40"},{"groupId":"OG004","value":"16.7","spread":"23.30"},{"groupId":"OG005","value":"13.4","spread":"25.68"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Dermatology Life Quality Index (DLQI) Score. up to Week 52, (Induction)","description":"The DLQI is a quality of life measure used in the psoriatic The 10-item questionnaire has a score range of 0 (best) to 30 (worst) with higher scores indicating poor quality of life. The instrument contains six functional scales (i.e., symptoms and feeling, daily activities, leisure, work and school, personal relationships, treatment). Each item has 4 response categories, ranging from 0 (not at all) to 3 (very much). \"Not relevant\" is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.5","spread":"5.02"},{"groupId":"OG001","value":"-6","spread":"5.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.2","spread":"6.11"},{"groupId":"OG001","value":"-8.7","spread":"6.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.2","spread":"6.40"},{"groupId":"OG001","value":"-10.3","spread":"6.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.8","spread":"6.75"},{"groupId":"OG001","value":"-11","spread":"7.01"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Dermatology Life Quality Index (DLQI) Score. up to Week 52, (Maintenance)","description":"The DLQI is a quality of life measure used in the psoriatic The 10-item questionnaire has a score range of 0 (best) to 30 (worst) with higher scores indicating poor quality of life. The instrument contains six functional scales (i.e., symptoms and feeling, daily activities, leisure, work and school, personal relationships, treatment). Each item has 4 response categories, ranging from 0 (not at all) to 3 (very much). \"Not relevant\" is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"-11","spread":"6.63"},{"groupId":"OG003","value":"-11.4","spread":"7.12"},{"groupId":"OG004","value":"-11.4","spread":"6.98"},{"groupId":"OG005","value":"-11.3","spread":"7.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.6","spread":"6.50"},{"groupId":"OG003","value":"-11","spread":"7.18"},{"groupId":"OG004","value":"-10.6","spread":"7.55"},{"groupId":"OG005","value":"-11","spread":"7.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.5","spread":"6.67"},{"groupId":"OG003","value":"-11.1","spread":"7.39"},{"groupId":"OG004","value":"-10.1","spread":"7.65"},{"groupId":"OG005","value":"-10.3","spread":"7.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.5","spread":"6.68"},{"groupId":"OG003","value":"-11","spread":"7.22"},{"groupId":"OG004","value":"-9.7","spread":"7.39"},{"groupId":"OG005","value":"-9.5","spread":"7.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.5","spread":"6.76"},{"groupId":"OG003","value":"-10.9","spread":"7.17"},{"groupId":"OG004","value":"-8.6","spread":"7.66"},{"groupId":"OG005","value":"-8.9","spread":"7.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.2","spread":"6.94"},{"groupId":"OG003","value":"-10.9","spread":"7.30"},{"groupId":"OG004","value":"-8.6","spread":"7.55"},{"groupId":"OG005","value":"-8.5","spread":"7.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.1","spread":"6.83"},{"groupId":"OG003","value":"-10.8","spread":"7.33"},{"groupId":"OG004","value":"-8.4","spread":"7.22"},{"groupId":"OG005","value":"-8.5","spread":"7.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10.2","spread":"6.72"},{"groupId":"OG003","value":"-10.8","spread":"7.46"},{"groupId":"OG004","value":"-8.4","spread":"7.07"},{"groupId":"OG005","value":"-8.6","spread":"7.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-10","spread":"6.57"},{"groupId":"OG003","value":"-10.8","spread":"7.38"},{"groupId":"OG004","value":"-8.6","spread":"7.41"},{"groupId":"OG005","value":"7.9","spread":"7.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"-9.8","spread":"7.06"},{"groupId":"OG003","value":"-10.9","spread":"7.31"},{"groupId":"OG004","value":"-8.4","spread":"7.46"},{"groupId":"OG005","value":"-7.6","spread":"7.14"}]}]}]},{"type":"SECONDARY","title":"% of Participants Achieving a DLQI Score of 0 or 1 at Each Visit up to Week 52, (Induction)","description":"The DLQI is a quality of life measure used in the psoriatic The 10-item questionnaire has a score range of 0 (best) to 30 (worst) with higher scores indicating poor quality of life. The instrument contains six functional scales (i.e., symptoms and feeling, daily activities, leisure, work and school, personal relationships, treatment). Each item has 4 response categories, ranging from 0 (not at all) to 3 (very much). \"Not relevant\" is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.5","spread":null},{"groupId":"OG001","value":"13.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.2","spread":null},{"groupId":"OG001","value":"33.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.7","spread":null},{"groupId":"OG001","value":"52.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.4","spread":null},{"groupId":"OG001","value":"63.1","spread":null}]}]}]},{"type":"SECONDARY","title":"% of Participants Achieving a DLQI Score of 0 or 1 at Each Visit up to Week 52, (Maintenance).","description":"The DLQI is a quality of life measure used in the psoriatic The 10-item questionnaire has a score range of 0 (best) to 30 (worst) with higher scores indicating poor quality of life. The instrument contains six functional scales (i.e., symptoms and feeling, daily activities, leisure, work and school, personal relationships, treatment). Each item has 4 response categories, ranging from 0 (not at all) to 3 (very much). \"Not relevant\" is also a valid response and is scored as 0. The DLQI total score is a sum of the 10 questions","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"59.8","spread":null},{"groupId":"OG003","value":"66.5","spread":null},{"groupId":"OG004","value":"58.4","spread":null},{"groupId":"OG005","value":"72.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"57.4","spread":null},{"groupId":"OG003","value":"67.6","spread":null},{"groupId":"OG004","value":"58","spread":null},{"groupId":"OG005","value":"69.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"58.4","spread":null},{"groupId":"OG003","value":"68.7","spread":null},{"groupId":"OG004","value":"53.9","spread":null},{"groupId":"OG005","value":"65.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"57.9","spread":null},{"groupId":"OG003","value":"70.1","spread":null},{"groupId":"OG004","value":"47.6","spread":null},{"groupId":"OG005","value":"51.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"57.9","spread":null},{"groupId":"OG003","value":"67.8","spread":null},{"groupId":"OG004","value":"37.9","spread":null},{"groupId":"OG005","value":"47.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"58.4","spread":null},{"groupId":"OG003","value":"65","spread":null},{"groupId":"OG004","value":"39.8","spread":null},{"groupId":"OG005","value":"39.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"55","spread":null},{"groupId":"OG003","value":"66.4","spread":null},{"groupId":"OG004","value":"35","spread":null},{"groupId":"OG005","value":"42.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"59.9","spread":null},{"groupId":"OG003","value":"68.7","spread":null},{"groupId":"OG004","value":"31.6","spread":null},{"groupId":"OG005","value":"43.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"54","spread":null},{"groupId":"OG003","value":"67.3","spread":null},{"groupId":"OG004","value":"32","spread":null},{"groupId":"OG005","value":"40.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"56.4","spread":null},{"groupId":"OG003","value":"69.2","spread":null},{"groupId":"OG004","value":"31.1","spread":null},{"groupId":"OG005","value":"37.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Time to Relapse (Weeks) From Week 12.","description":"Median time to relapse (weeks) from week 12. Relapse is defined as greater than 50% loss of the maximal PASI improvement from baseline. PASI is a combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72(maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section (head: 0.1, arms: 0.2 body: 0.3 legs: 0.4). A negative mean percentage change indicates improvement","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"NA","spread":null},{"groupId":"OG003","value":"NA","spread":null},{"groupId":"OG004","value":"NA","spread":null},{"groupId":"OG005","value":"302","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent of Responders With PASI Equal to or Greater Than 50, PASI 75, PASI 90, PASI 100 and Percent of Responders With IGA Score of 0 or 1 Who Failed to Respond to a Previous Biologic Psoriasis Therapy","description":"PASI is a combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72 (maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section (head: 0.1, arms: 0.2 body: 0.3 legs: 0.4). PASI 50, 75, 90 and 100 were defined as participants achieving ≥ 50%, 75%, 90% or 100% improvement from baseline. The IGA mod 2011 scale is static, i.e. it referred exclusively to the participant's disease at the time of the assessment, and did not compare with any of the participant's previous disease states at previous visits. The scores are: 0 = clear, 1 = almost clear, 2 = mild, 3 = moderate and 4 = severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.2","spread":null},{"groupId":"OG001","value":"62.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"87.5","spread":null},{"groupId":"OG001","value":"90.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.8","spread":null},{"groupId":"OG001","value":"86.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.6","spread":null},{"groupId":"OG001","value":"56.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":null},{"groupId":"OG001","value":"21.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent of Responders With PASI Equal to or Greater Than 50, PASI 75, PASI 90, PASI 100 and Percent of Responders With IGA Score of 0 or 1 Who Failed to Respond to a Previous Biologic Psoriasis Therapy","description":"PASI is a combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72 (maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section (head: 0.1, arms: 0.2 body: 0.3 legs: 0.4). PASI 50, 75, 90 and 100 were defined as participants achieving ≥ 50%, 75%, 90% or 100% improvement from baseline. The IGA mod 2011 scale is static, i.e. it referred exclusively to the participant's disease at the time of the assessment, and did not compare with any of the participant's previous disease states at previous visits. The scores are: 0 = clear, 1 = almost clear, 2 = mild, 3 = moderate and 4 = severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"42.9","spread":null},{"groupId":"OG003","value":"66.7","spread":null},{"groupId":"OG004","value":"4.3","spread":null},{"groupId":"OG005","value":"14.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"81","spread":null},{"groupId":"OG003","value":"86.1","spread":null},{"groupId":"OG004","value":"60.9","spread":null},{"groupId":"OG005","value":"75","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"47.6","spread":null},{"groupId":"OG003","value":"77.8","spread":null},{"groupId":"OG004","value":"21.7","spread":null},{"groupId":"OG005","value":"32.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"33.3","spread":null},{"groupId":"OG003","value":"66.7","spread":null},{"groupId":"OG004","value":"13","spread":null},{"groupId":"OG005","value":"7.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"28.6","spread":null},{"groupId":"OG003","value":"52.8","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"3.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Visits With PASI 50, 75, 90, 100 Score and IGA Mod 2011 0 or 1","description":"PASI is a combined assessment of lesion severity and affected area into a single score: 0 (no disease) to 72 (maximal disease). Body is divided into 4 areas for scoring (head, arms, trunk, legs; each area is scored by itself and scores are combined for final PASI. For each area, percent of skin involved is estimated: 0 (0%) to 6 (90-100%), and severity is estimated by clinical signs, erythema, induration and desquamation; scale 0 (none) to 4 (maximum). Final PASI = sum of severity parameters for each area\\* area score weight of section (head: 0.1, arms: 0.2 body: 0.3 legs: 0.4). PASI 50, 75, 90 and 100 were defined as participants achieving ≥ 50%, 75%, 90% or 100% improvement from baseline. The IGA mod 2011 scale is static, i.e. it referred exclusively to the participant's disease at the time of the assessment, and did not compare with any of the participant's previous disease states at previous visits. The scores are: 0 = clear, 1 = almost clear, 2 = mild, 3 = moderate and 4 = severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"1.5","spread":null},{"groupId":"OG003","value":"0.9","spread":null},{"groupId":"OG004","value":"0.5","spread":null},{"groupId":"OG005","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0.5","spread":null},{"groupId":"OG004","value":"1.5","spread":null},{"groupId":"OG005","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.5","spread":null},{"groupId":"OG003","value":"0.5","spread":null},{"groupId":"OG004","value":"3.4","spread":null},{"groupId":"OG005","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"0.5","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"3.4","spread":null},{"groupId":"OG005","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"1.5","spread":null},{"groupId":"OG003","value":"2.8","spread":null},{"groupId":"OG004","value":"4.4","spread":null},{"groupId":"OG005","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"0.5","spread":null},{"groupId":"OG004","value":"2.4","spread":null},{"groupId":"OG005","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.5","spread":null},{"groupId":"OG003","value":"0.5","spread":null},{"groupId":"OG004","value":"4.9","spread":null},{"groupId":"OG005","value":"0.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"3.2","spread":null},{"groupId":"OG004","value":"6.8","spread":null},{"groupId":"OG005","value":"5.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"10.2","spread":null},{"groupId":"OG005","value":"12.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"8.4","spread":null},{"groupId":"OG003","value":"7.9","spread":null},{"groupId":"OG004","value":"8.7","spread":null},{"groupId":"OG005","value":"16.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"72.9","spread":null},{"groupId":"OG003","value":"79.6","spread":null},{"groupId":"OG004","value":"53.9","spread":null},{"groupId":"OG005","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.9","spread":null},{"groupId":"OG003","value":"3.2","spread":null},{"groupId":"OG004","value":"3.9","spread":null},{"groupId":"OG005","value":"2.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.9","spread":null},{"groupId":"OG003","value":"2.8","spread":null},{"groupId":"OG004","value":"6.8","spread":null},{"groupId":"OG005","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":null},{"groupId":"OG003","value":"2.8","spread":null},{"groupId":"OG004","value":"8.3","spread":null},{"groupId":"OG005","value":"4.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"3.2","spread":null},{"groupId":"OG004","value":"7.8","spread":null},{"groupId":"OG005","value":"6.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.9","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"11.2","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"10.7","spread":null},{"groupId":"OG005","value":"10.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.9","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"11.7","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.4","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"9.2","spread":null},{"groupId":"OG005","value":"11.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.5","spread":null},{"groupId":"OG003","value":"4.2","spread":null},{"groupId":"OG004","value":"9.7","spread":null},{"groupId":"OG005","value":"18.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"7.4","spread":null},{"groupId":"OG003","value":"8.8","spread":null},{"groupId":"OG004","value":"10.7","spread":null},{"groupId":"OG005","value":"15.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"53.2","spread":null},{"groupId":"OG003","value":"65.7","spread":null},{"groupId":"OG004","value":"10.2","spread":null},{"groupId":"OG005","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"24.6","spread":null},{"groupId":"OG003","value":"12","spread":null},{"groupId":"OG004","value":"23.8","spread":null},{"groupId":"OG005","value":"15.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.4","spread":null},{"groupId":"OG003","value":"5.1","spread":null},{"groupId":"OG004","value":"15","spread":null},{"groupId":"OG005","value":"7.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.5","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"8.3","spread":null},{"groupId":"OG005","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":null},{"groupId":"OG003","value":"4.2","spread":null},{"groupId":"OG004","value":"6.8","spread":null},{"groupId":"OG005","value":"11.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.4","spread":null},{"groupId":"OG003","value":"2.3","spread":null},{"groupId":"OG004","value":"11.2","spread":null},{"groupId":"OG005","value":"11.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.9","spread":null},{"groupId":"OG003","value":"1.4","spread":null},{"groupId":"OG004","value":"8.7","spread":null},{"groupId":"OG005","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"5.1","spread":null},{"groupId":"OG004","value":"9.7","spread":null},{"groupId":"OG005","value":"8.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.9","spread":null},{"groupId":"OG003","value":"4.6","spread":null},{"groupId":"OG004","value":"7.3","spread":null},{"groupId":"OG005","value":"10.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":null},{"groupId":"OG003","value":"6.5","spread":null},{"groupId":"OG004","value":"2.9","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"13.8","spread":null},{"groupId":"OG003","value":"13.4","spread":null},{"groupId":"OG004","value":"2.9","spread":null},{"groupId":"OG005","value":"3.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"28.1","spread":null},{"groupId":"OG003","value":"41.7","spread":null},{"groupId":"OG004","value":"3.4","spread":null},{"groupId":"OG005","value":"4.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"53.2","spread":null},{"groupId":"OG003","value":"41.2","spread":null},{"groupId":"OG004","value":"65","spread":null},{"groupId":"OG005","value":"51.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.9","spread":null},{"groupId":"OG003","value":"6.5","spread":null},{"groupId":"OG004","value":"9.7","spread":null},{"groupId":"OG005","value":"7.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.9","spread":null},{"groupId":"OG003","value":"4.2","spread":null},{"groupId":"OG004","value":"6.3","spread":null},{"groupId":"OG005","value":"12.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"4.6","spread":null},{"groupId":"OG004","value":"7.3","spread":null},{"groupId":"OG005","value":"8.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"2.3","spread":null},{"groupId":"OG004","value":"6.3","spread":null},{"groupId":"OG005","value":"6.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"5.6","spread":null},{"groupId":"OG004","value":"2.9","spread":null},{"groupId":"OG005","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.9","spread":null},{"groupId":"OG003","value":"5.1","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.4","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"0.5","spread":null},{"groupId":"OG005","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2.5","spread":null},{"groupId":"OG003","value":"5.6","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"4.4","spread":null},{"groupId":"OG003","value":"7.9","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"8.9","spread":null},{"groupId":"OG003","value":"13.4","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"19.2","spread":null},{"groupId":"OG003","value":"11.6","spread":null},{"groupId":"OG004","value":"20.4","spread":null},{"groupId":"OG005","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"10.2","spread":null},{"groupId":"OG005","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"9.7","spread":null},{"groupId":"OG005","value":"7.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.4","spread":null},{"groupId":"OG003","value":"5.1","spread":null},{"groupId":"OG004","value":"9.2","spread":null},{"groupId":"OG005","value":"10.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.9","spread":null},{"groupId":"OG003","value":"3.2","spread":null},{"groupId":"OG004","value":"8.3","spread":null},{"groupId":"OG005","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"3.4","spread":null},{"groupId":"OG003","value":"1.9","spread":null},{"groupId":"OG004","value":"10.2","spread":null},{"groupId":"OG005","value":"13.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.4","spread":null},{"groupId":"OG003","value":"4.6","spread":null},{"groupId":"OG004","value":"9.2","spread":null},{"groupId":"OG005","value":"7.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.4","spread":null},{"groupId":"OG003","value":"3.7","spread":null},{"groupId":"OG004","value":"7.8","spread":null},{"groupId":"OG005","value":"10.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"5.9","spread":null},{"groupId":"OG003","value":"2.8","spread":null},{"groupId":"OG004","value":"5.8","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"6.4","spread":null},{"groupId":"OG003","value":"12.5","spread":null},{"groupId":"OG004","value":"3.9","spread":null},{"groupId":"OG005","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG002","value":"35.5","spread":null},{"groupId":"OG003","value":"47.2","spread":null},{"groupId":"OG004","value":"5.3","spread":null},{"groupId":"OG005","value":"5.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Secukinumab Injections Needed to Regain PASI 75 Response From Start of Relapse After Week 12","description":"The number of secukinumab injections needed for participants to regain PASI 75 response from the start of relapse after week 12","classes":[{"categories":[{"measurements":[{"groupId":"OG004","value":"4.1","spread":null},{"groupId":"OG005","value":"0.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"40.2","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"27.8","spread":null},{"groupId":"OG005","value":"45.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"11.3","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"6.2","spread":null},{"groupId":"OG005","value":"31.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"4.1","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"4.1","spread":null},{"groupId":"OG005","value":"14.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"3.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"1.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"5.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"47.6","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"42.9","spread":null},{"groupId":"OG005","value":"58.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"4.8","spread":null},{"groupId":"OG005","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"19.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"4.8","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"8.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG004","value":"NA","spread":null},{"groupId":"OG005","value":"100","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Developing Anti-secukinumab Antibodies","description":"The development of anti-secunimubab anti-bodies will decrease a participant's ability to respond to secukinumab treatment. The number of participants developing anti-secukinumab anti-bodies was measured from Baseline to week 12, 24, 52 and 8 weeks after treatment at week 60","classes":[{"categories":[{"measurements":[{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":482},"commonTop":["NASOPHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION","HEADACHE","PRURITUS","HYPERTENSION"]}}}